1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > 2015 Strategies in the E. Coli Diagnostic Testing Market

2015 Strategies in the E. Coli Diagnostic Testing Market

  • May 2015
  • -
  • Venture Planning Group
  • -
  • 200 pages

The report contains 200 pages, 7 tables and presents a detailed analysis of the E. Coli diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the E. Coli definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:

     - Hospitals
     - Commercial/Private Labs
     - Physician Offices
     - Public Health Labs

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 200 pages and 7 tablesThe report contains 200 pages, 7 tables and presents a detailed analysis of the E. Coli diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the E. Coli definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:

     - Hospitals
     - Commercial/Private Labs
     - Physician Offices
     - Public Health Labs

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 200 pages and 7 tables

Table Of Contents

2015 Strategies in the E. Coli Diagnostic Testing Market
I. Introduction
II. E. COLI Worldwide Market and Technology Overview
A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
III. France: Test Volume and Diagnostics Sales Forecast
by Market Segment

IV. Germany: Test Volume and Diagnostics Sales Forecast
by Market Segment
V. Italy: Test Volume and Diagnostics Sales Forecast
by Market Segment
VI. Japan: Test Volume and Diagnostics Sales Forecast
by Market Segment
VII. Spain: Test Volume and Diagnostics Sales Forecast
by Market Segment
VIII. UK: Test Volume and Diagnostics Sales Forecast
by Market Segment

IX. USA: Test Volume and Diagnostics Sales Forecast
by Market Segment
W. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. Competitive Assessments

- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin

- Eiken Chemical
- Enzo Biochem
- Fujirebio
- Hologic/Gen-Probe
- ID Biomedical
- Innogenetics/Solvay
- Kreatech/Leica
- Life Technology/Thermo Fisher
- Lonza
- Nanogen/Elitech Group
- Novartis Diagnostics/Grifols
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac
- Wako
E. COLI DIAGNOSTICS MARKET: US, EUROPE, JAPAN
Test Volume and Sales Forecasts by Country


List of Tables
France
E. Coli Test Volume and Diagnostics Sales Forecast
by Market Segment
Germany
E. Coli Test Volume and Diagnostics Sales Forecast
by Market Segment
Italy
E. Coli Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
E. Coli Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
E. Coli Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
E. Coli Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
E. Coli Test Volume and Diagnostics Sales Forecast
by Market Segment

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 Europe Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 Europe Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 36000
  • Industry report
  • February 2017
  • by Venture Planning Group

This new 31-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as ...

Cancer Diagnostics 2017-2021: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

Cancer Diagnostics 2017-2021: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 21100
  • Industry report
  • December 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. The report is available by country, section, market segment, and can be custom-tailored to your specific information ...

2017 Asia-Pacific Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 Asia-Pacific Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 11300
  • Industry report
  • February 2017
  • by Venture Planning Group

This new 17-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.